Výsledky vyhledávání

Akademický článek

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

Autor: Charlotte Höybye, Beverly M K Biller, Jean-Marc Ferran, Murray B Gordon, Nicky Kelepouris, Navid Nedjatian, Anne H Olsen, Matthias M Weber

Publikováno v: Endocrine Connections, Vol 12, Iss 1, Pp 1-13 (2022)

Adult growth hormone deficiency (AGHD) is associated with an increased risk of cardiovascular (CV) disease. Long-term growth hormone (GH) trea tment could improve CV outcomes. The objective of this study was to evaluate CV disease risk in patients wi

Externí odkaz: https://doaj.org/article/21868611a031471599f8d579043b1b21

Zobrazit plný text záznamu

Akademický článek

Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial

Autor: Ghina Tsurayya, Cut Alifiya Nazhifah, Muhammad Rahmat Pirwanja, Putri Oktaviani Zulfa, Muhammad Raihan Ramadhan Tatroman, Fajar Fakri, Muhammad Iqhrammullah

Publikováno v: Children, Vol 11, Iss 2, p 227 (2024)

Growth hormone treatment has effectively restored normal growth in children with growth hormone deficiency (GHD); however, it poses challenges in compliance with a daily growth hormone injection regimen, leading to low adherence and persistence rates

Externí odkaz: https://doaj.org/article/a2b1149afc6a4812ae56d08b735908a5

Zobrazit plný text záznamu

Akademický článek

Clinicians’ Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19

Autor: Blair J, Warth K, Suvarna Y, Cappa M

Publikováno v: Patient Preference and Adherence, Vol Volume 15, Pp 2113-2123 (2021)

Joanne Blair, 1 Kelly Warth, 2 Yashasvi Suvarna, 3 Marco Cappa 4 1Department of Endocrinology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK; 2Instar, London, UK; 3Global Medical Affairs, Novo Nordisk Global Business Services (GBS), Bang

Externí odkaz: https://doaj.org/article/08cf1fa76b764d86820f6c1949e22361

Zobrazit plný text záznamu

Clinicians’ Feedback on Patient/Carer Experience After Switching of Growth Hormone Treatment in Pediatric Patients During COVID-19

Autor: Yashasvi Suvarna, Marco Cappa, Joanne Blair, Kelly Warth

Publikováno v: Patient preference and adherence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b636c4661e3006e3182ab04af79d5d
http://europepmc.org/articles/PMC8464361

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age

Autor: Susumu Yokoya, Reiko Horikawa, Hiromi Nishinaga, Yosuke Nishiba, Toshiaki Tanaka

Publikováno v: Clinical Pediatric Endocrinology

This study aimed to characterize the safety and effectiveness of GH treatments, in usual clinical practice, in children with short stature born small for gestational age (SGA). This was a multicenter, open-label, non-interventional study (NCT01110928

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffd36dd839e34f6376dfdd22de76b84
https://doi.org/10.1297/cpe.29.159

Zobrazit plný text záznamu

Long-term efficacy and safety of two doses of Norditropin® (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients

Autor: Susumu Yokoya, Keiichi Ozono, Yoshihisa Ogawa, Reiko Horikawa, Keiji Nishijima, Tsutomu Ogata, Takaaki Endo, Yoichi Matsubara

Publikováno v: Endocrine Journal. 67:803-818

This 4-year randomized, double-blind, multicenter trial (NCT01927861) investigated the long-term efficacy and safety of Norditropin® (NN-220; somatropin) in Japanese children with short stature due to Noonan syndrome. Pre-pubertal children with Noon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c4f4afe26af220e36c865b42006301e
https://doi.org/10.1507/endocrj.ej19-0371

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání